Seno Medical Instruments Appoints Steve Miller as SVP of Engineering
SAN ANTONIO, Jan. 18, 2017 /PRNewswire/ – Seno Medical Instruments, Inc., the leader in improving the process of diagnosing breast cancer through the development of an opto-acoustic (OA/US) imaging device, today announced the appointment of Steve Miller as SVP of Engineering. Mr. Miller previously served as the Vice President of Product Realization at FUJIFILM SonoSite, […]
New Data Presented at San Antonio Breast Cancer Symposium Confirms Correlation Between the Imagio™ Opto-Acoustic Breast Imaging System and Histologic Grade of Breast Masses
Additional Data Validates Potential of Imagio™ Opto-Acoustic Breast Imaging System to Reduce Negative Biopsies NEWS PROVIDED BY Seno Medical Instruments, Inc. Dec 09, 2016, 07:00 ET SAN ANTONIO, Dec. 9, 2016 /PRNewswire/ — Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic (OA) technology as a new tool to improve the process of diagnosing […]
Updated Data from Pivotal European Study at 2016 San Antonio Breast Cancer Symposium
Seno Medical Instruments to Present Updated Data from Pivotal European Study at 2016 San Antonio Breast Cancer Symposium SAN ANTONIO, Dec. 5, 2016 — Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, today announced that it will present data […]
Company Plans to Deliver First Imagio™ Opto-Acoustic (OA) Breast Imaging Systems to Select Markets in Europe in Early 2017
New Interim Results Support Imagio™ Opto-acoustic (OA) Breast Imaging System’s Potential to Reduce Negative Biopsies SAN ANTONIO, Sept. 24, 2016 — Seno Medical Instruments, Inc. (Seno), the company pioneering the development of opto-acoustic technology as a tool to improve the process of diagnosing breast cancer, announced today interim results from the company’s multicenter, European MAESTRO post-market surveillance […]
Seno Medical Instruments Appoints Eric Davis as Chief Financial Officer
SAN ANTONIO, August, 8 2016 – Seno Medical Instruments, Inc., the leader in improving the process of diagnosing breast cancer through the development of an opto-acoustic (OA) imaging device, today announced the appointment of Eric Davis as Chief Financial Officer. Mr. Davis previously served as the Chief Financial Officer and Corporate Treasurer at CeloNova BioSciences, Inc. Mr. […]
Seno Medical Instruments Appoints Tammy Garcia as SVP of Sales & Marketing
SAN ANTONIO, August 1 , 2016 – Seno Medical Instruments, Inc., the leader in improving the process of diagnosing breast cancer through the development of an opto-acoustic (OA) imaging device, today announced the appointment of Tammy Garcia as Senior Vice President of Sales & Marketing. Ms. Garcia previously served as the General Manager, Breast Imaging for GE […]
Seno Medical Instruments Appoints Tom Umbel as Chief Executive Officer
SAN ANTONIO, Feb. 1, 2016 /PRNewswire/ — Seno Medical Instruments, Inc., the leader in improving the process of diagnosing breast cancer through the development of an opto-acoustic (OA) device, today announced the appointment of Tom Umbel as Chief Executive Officer. Mr. Umbel previously served as the Vice President of Business Development for Bioventus, a privately […]
Using a Real-Time Predictive Model to Interpret Images from Seno Medical Instruments Imagio Breast
SAN ANTONIO, Nov. 3, 2014 /PRNewswire/ — Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, announced that the use of the Seno Imagio breast imaging system and the associated predictive model appear to have the potential to significantly improve […]
Seno to Present at the Cleveland Clinic’s 12th Annual Medical Innovation Summit
SAN ANTONIO, Oct. 23, 2014 /PRNewswire/ — Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, today announced that Janet Campbell-Clark, Chief Executive Officer, will be presenting a corporate overview at the Cleveland Clinic’s 2014 Medical Innovation Summit to be held […]
Seno Completes Patient Enrollment in U.S. Pivotal Study of Imagio™ Breast Imaging System
SAN ANTONIO, TX – September 23, 2014 – Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, announced today it has completed active enrollment of subjects in its U.S.-based PIONEER Pivotal Study of Imagio™. The study was designed to determine […]